It is well known that the EGFR-sensitive mutation enhances the phosphorylation of MAPK and Akt in NSCLC, and our previous studies and others had documented that GPER1 can stimulate the phosphorylation of MAPK and Akt through activation of EGFR in breast cancer. This evidence concerns the gene GPER1 and breast cancer.